CLINICAL_TRIALS
trial_result
· 2014-03-05
Clinical Trial Update: GLORIA-AF Registry Program (Phase I)
Summary
The GLORIA-AF Registry Program Phase I update from Boehringer Ingelheim in atrial fibrillation has completed, with results posted in March 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation | Status: COMPLETED | Results posted: 2014-03-05